Skip to content
CNS Clinical Research

South Carolina

CNS clinical trials in South Carolina

62 CNS studies are recruiting participants at sites in 20 cities across South Carolina as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every South Carolina city with a recruiting study

By research area: Depression (25), Parkinson's Disease (15), ADHD (7), Multiple Sclerosis (6), Migraine (5), Epilepsy (2), Schizophrenia (2).

Charleston (43), Greenville (9), North Charleston (8), Anderson (1), Beaufort (1), Bluffton (1), Boiling Springs (1), Columbia (1), Easley (1), Florence (1), Fort Mill (1), Gaffney (1), Georgetown (1), Greer (1), Lancaster (1), Orangeburg (1), Port Royal (1), Rock Hill (1), Seneca (1), Summerville (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in South Carolina

Basic details from each study's public record (the 12 most recently updated of 62). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care

    • No phase
    • Ages 21 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Charleston
    Registry record
    NCT04877197 · updated
  2. A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Definium Therapeutics US, Inc.
    Recruiting in
    North Charleston
    Registry record
    NCT07592689 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in South Carolina on ClinicalTrials.gov.

Schizophrenia: recently updated in South Carolina

  1. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Recruiting in
    Port Royal
    Registry record
    NCT06887192 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in South Carolina on ClinicalTrials.gov.

ADHD: recently updated in South Carolina

  1. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    • Phase 3
    • Ages 6 to 11
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    North Charleston
    Registry record
    NCT07717879 · updated
  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    North Charleston
    Registry record
    NCT07717892 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in South Carolina on ClinicalTrials.gov.

Parkinson's disease: recently updated in South Carolina

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Charleston
    Registry record
    NCT06989112 · updated
  2. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Charleston · Greenville
    Registry record
    NCT06966700 · updated
  3. Accelerated rTMS for Apathy in Parkinson's Disease

    • No phase
    • Ages 45 to 85
    • All sexes
    Sponsor
    Medical University of South Carolina
    Recruiting in
    Charleston
    Registry record
    NCT07399496 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in South Carolina on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in South Carolina

  1. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Greenville
    Registry record
    NCT07299019 · updated
  2. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Greenville
    Registry record
    NCT07067463 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in South Carolina on ClinicalTrials.gov.

Migraine: recently updated in South Carolina

  1. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Recruiting in
    Charleston
    Registry record
    NCT07616128 · updated
  2. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Anderson · Gaffney
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in South Carolina on ClinicalTrials.gov.

Ask about studies in South Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call